{"schema_version":"1","generated_at":"2026-11-07T08:44:14.081Z","data_as_of":null,"url":"https://www.findmykol.com/kol/takeo-fujii","json_url":"https://www.findmykol.com/kol/takeo-fujii/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"takeo-fujii","name":"Takeo Fujii","credential":"MD, MPH","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"National Institutes of Health","institution_url":"https://www.findmykol.com/institution/national-institutes-of-health","city":"Bethesda","state":"MD","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1598132573","orcid":"0000-0003-3747-2688","openalex":"A5112215616"},"summary":"Takeo Fujii is an Oncology physician affiliated with National Institutes of Health. OpenAlex indexes 81 publications with 1,520 citations (h-index 19); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":81,"cited_by_count":1520,"h_index":19,"latest_activity_year":2026,"emerging":true,"source":"works"},"trials":{"count":1,"shown":3,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT07619534","title":"Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain Metastases","status":"RECRUITING","role":"Overall official","sponsor":"National Cancer Institute (NCI)","source_url":"https://clinicaltrials.gov/study/NCT07619534","trial_url":"https://www.findmykol.com/trial/NCT07619534"},{"nct":"NCT03762733","title":"Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies","status":"ENROLLING_BY_INVITATION","role":"Overall official","sponsor":"National Cancer Institute (NCI)","source_url":"https://clinicaltrials.gov/study/NCT03762733","trial_url":"https://www.findmykol.com/trial/NCT03762733"},{"nct":"NCT02484404","title":"Phase I/II Study of the Anti-Programmed Death Ligand-1 Durvalumab Antibody (MEDI4736) in Combination With Olaparib and/or Cediranib for Advanced Solid Tumors and Advanced or Recurrent Ovarian, Triple Negative Breast, Lung, Prostate and Colorectal Can...","phase":"PHASE1/PHASE2","status":"ACTIVE_NOT_RECRUITING","role":"Overall official","sponsor":"National Cancer Institute (NCI)","source_url":"https://clinicaltrials.gov/study/NCT02484404","trial_url":"https://www.findmykol.com/trial/NCT02484404"}],"source":"trials"},"payments":{"company_count":1,"program_years":{"first":2021,"last":null},"rows_total":1,"shown":1,"withheld":0,"rows":[{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2021,"amount_usd":104.12,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1598132573"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1598132573","source":"payments"},"prescribing":{"data_year":2019,"areas_total":2,"areas_shown":2,"areas":[{"area":"Cardiovascular","share_pct":59.3,"classes_total":1,"classes":[{"class":"Statin","setting":"prescribed","share_pct":59.3,"drugs":[{"name":"Atorvastatin Calcium","share_pct":100}],"max_beneficiaries":null}]},{"area":"Nervous system","share_pct":40.7,"classes_total":1,"classes":[{"class":"Gabapentinoids","setting":"prescribed","share_pct":40.7,"drugs":[{"name":"Gabapentin","share_pct":100}],"max_beneficiaries":null}]}],"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Payload Diversification Overcomes Resistance and Guides Sequential Antibody–Drug Conjugate Therapy in Breast Cancer","year":2026,"journal":"Clinical Cancer Research","source_url":"https://doi.org/10.1158/1078-0432.ccr-25-3321","status":"verified"},{"title":"Neutrophils drive vascular occlusion, tumour necrosis and metastasis","year":2025,"journal":"Nature","source_url":"https://doi.org/10.1038/s41586-025-09278-3","status":"verified"},{"title":"A CSF-1R inhibitor both prevents and treats triple-negative breast cancer brain metastases in hematogenous preclinical models","year":2025,"journal":"Clinical & Experimental Metastasis","source_url":"https://doi.org/10.1007/s10585-025-10366-x","status":"verified"},{"title":"Healthcare provider perspectives on a clinical decision tool to support individualized exercise prescriptions and discussions for breast cancer survivors","year":2025,"journal":"Journal of Cancer Survivorship","source_url":"https://doi.org/10.1007/s11764-025-01750-3","status":"verified"},{"title":"Revisiting surrogacy of pathological complete response for long-term survival in triple-negative breast cancer","year":2025,"journal":"JNCI Cancer Spectrum","source_url":"https://doi.org/10.1093/jncics/pkaf022","status":"verified"}],"source":"works"},"contact":{"address_1":"10 CENTER DR","city":"Bethesda","state":"MD","zip":"208924000","phone":"240-858-3558","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1598132573","source":"identity"},"similar":[{"name":"Henry Masur","slug":"henry-masur","institution":"National Institutes of Health","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/henry-masur","json_url":"https://www.findmykol.com/kol/henry-masur/profile.json"},{"name":"Tim Greten","slug":"tim-greten","institution":"National Institutes of Health","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/tim-greten","json_url":"https://www.findmykol.com/kol/tim-greten/profile.json"},{"name":"Joel Moss","slug":"joel-moss","institution":"National Institutes of Health","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/joel-moss","json_url":"https://www.findmykol.com/kol/joel-moss/profile.json"},{"name":"Lynnette Nieman","slug":"lynnette-nieman","institution":"National Institutes of Health","specialty":"Endocrinology, Diabetes & Metabolism","url":"https://www.findmykol.com/kol/lynnette-nieman","json_url":"https://www.findmykol.com/kol/lynnette-nieman/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2025-01-10","provider_certified":"2025-01-10","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2019}},"methodology_url":"https://www.findmykol.com/about#methodology"}